Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases

Pancreatology

Volumn 6, Issue 4, 2006, Pages 268-272

  Özkan, Hasan ^a   Akar, Tarik ^a   Köklü, Seyfettin ^b,c   Çoban, Şahin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b M I Kastamonu State Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

CA19 9 pancreas tumor marker; Pancreatic cancer; RCAS1 antigen

Indexed keywords

CA 19-9 ANTIGEN; RCAS1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; BLOOD LEVEL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; RECEPTOR BINDING; SENSITIVITY AND SPECIFICITY;

EID: 33748319460     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000092687     Document Type: Article

References (26)

1. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-1509.
2. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-493.
3. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N: Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-451.
4. Fukuda M, Tanaka A, Hamao A, Suzuki S, Kusama K, Sakashita H: Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity. Oncol Rep 2004;12:259-267.
5. Muta K, Ohshima K, Abe Y, Uike N, Choi I, Watanabe T, Nawata H: Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma. Int J Hematol 2004;79:340-344.
6. Nakamura Y, Yamazaki K, Oizumi S, Nakashima M, Watanabe T, Dosaka-Akita H, Nishimura M: Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci 2004;95:260-265.
7. Ikeguchi M, Ohoro S, Maeda Y, Yamaguchi K, Kondo A, Tsujitani S, Kaibara N: Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma. Oncol Rep 2003;10:1891-1894.
8. Ikeguchi M, Hirooka Y, Kaibara N: Gene and protein expression of RCAS1 in hepatocellular carcinoma. Anticancer Res 2003;23:4967-4971.
9. Okada K, Nakashima M, Komuta K, Hashimoto S, Okudaira S, Baba N, Hishikawa Y, Koji T, Kanematsu T, Watanabe T: Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol 2003;16:679-685.
10. Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A: Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Oncology 2003;64:83-89.
11. Takahashi S, Urano T, Tsuchiya F, Fujimura T, Kitamura T, Ouchi Y, Muramatsu M, Inoue S: EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int J Cancer 2003;106:310-315.
12. Watanabe H, Enjoji M, Nakashima M, Noguchi K, Kinukawa N, Sugimoto R, Kotoh K, Nakamuta M, Nawata H, Watanabe T: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J Hepatol 2003;39:559-563.
13. Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003;26:49-55.
14. Enjoji M, Yamaguchi K, Nakamuta M, Nakashima M, Kotoh K, Tanaka M, Nawataa H, Watanabe T: Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases. Dig Liver Dis 2004;36:622-627.
15. Ohshima K, Muta K, Nakashima M, Haraoka S, Tutiya T, Suzumiya J, Kawasaki C, Watanabe T, Kikuchi M: Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer 2001;93:91-96.
16. Hiraoka K, Hida Y, Miyamoto M, Oshikiri T, Suzuoki M, Nakakubo Y, Shinohara T, Itoh Y, Shichinohe T, Kondo S, Kasahara N, Katoh H: High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer 2002;99:418-423.
17. Oshikiri T, Hida Y, Miyamoto M, Hasahida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H: RCAS1 as a tumor progression marker, an independent negative prognostic factor in gallbladder cancer. Br J Cancer 2001;85:1922-1927.
18. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K, Tsuneyoshi M, Nawata H, Watanabe T: Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
19. Kobari M, Matsuno S: Staging systems for pancreatic cancer: differences between the Japanese and UICC systems. J Hepatobiliary Pancreat Surg 1998;5:121-127.
20. Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J Hepatol 2002;36:786-792.
21. Enjoji M, Nakamuta M, Noguchi K, Sugimoto R, Kotoh K, Nawata H, Nakashima M, Watanabe T: RCAS1 expression in immune-mediated liver diseases. J Clin Gastroenterol 2002;34:286-287.
22. Sawabu N, Watanabe H, Yamaguchi Y, Ohtsubo K, Motoo Y: Serum tumor markers and molecular biological diagnosis in pancreatic cancer. Pancreas 2004;28:263-267.
23. Ozkan H, Kaya M, Cengiz A: Comparison of tumor marker CA242 with CA19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology 2003; 50:1669-1674.
24. Duffy MJ: CA19-9 as a marker for gastrointestinal cancers: a review. Ann Clin Biochem 1998;35(Pt 3):364-370.
25. Steinberg W: The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-355.
26. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW: Clinical usefulness of carbohydrate antigen CA19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004;19:182-186.